| |
|
|
|
Alpine Immune Sciences Inc.  
|
|
5 0.37 (0.08%) |
08-23 15:55 |
|
Open: |
5 |
Pre close: |
4.63 |
Target:
|
6.07 
|
|
High: |
5 |
Low: |
4.5 |
Resistance:
|
5.20
6.07
|
|
Volume: |
588 |
Market Cap: |
93M |
Support:
|
4.09
3.41
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.80
 |
MACD |
MACD(12,26):
|
0.13 |
|
MA(20): |
4.14 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
5.16 |
Stochastic Oscillator |
%K(14,3):
|
78.21 |
|
MA(250): |
5.49 |
%D(3): |
76.60 |
|
Average Volume(K) |
3-Month: |
1068
|
52-Week |
High:
|
8.24 |
|
10-Days: |
1716 |
Low: |
3.41 |
|
RSI |
RSI(14):
|
64.52 |
Change(%): |
-20.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.971 |
Return on Equity (ttm) |
-84.9 |
Shares Out. (M) |
13.85 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-42.5 |
Shares Float (M) |
3.91 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
39.78 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
45.4 |
% Held by Institutions |
46.54 |
|
Forward EPS |
-2.604 |
Gross Profit (p.s.) |
-2.041 |
Shares Short (K) |
20 |
|
Book Value (p.s.) |
2.440 |
EBITDA (p.s.) |
-3.455 |
P/E |
-1.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.05 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
1731250048.00 |
|
Operating Margin |
-8585.18 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
